“All doctors who deal with IBD therapy with TNF-alpha inhibitors will reinforce their attention in the first ninety days, especially to skin and soft tissue infections,” Dr. Chebli, who was not involved in the study, told Reuters Health by email. “Other studies need to be done to conclude if this reduction after ninety days is maintained.”